The IFPMA Welcomes Nicholas Piramal India Limited
Main Category: Pharmacy / PharmacistArticle Date: 29 Sep 2007 - 19:00 PDT
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) is pleased to announce that its newest member company is Nicholas Piramal India Ltd..
Dr. Harvey Bale, Director General of the IFPMA, said: "We very much welcome Nicholas Piramal, not only as our newest member, but also as our first pharmaceutical company member from India. Piramal's membership of the IFPMA underlines that, in the future, research-based pharmaceutical leadership will not be the exclusive preserve of companies from Europe, Japan or the United States."
Nicholas Piramal India Limited has novel lead compounds in the fields of oncology, inflammation, infectious diseases and diabetes. Its comprehensive R&D organization covers a wide range of activities, including natural products (microbial and plant extracts), herbs (Indian traditional medicinal plants), medicinal and synthetic chemistry, special projects (looking at medicine combinations), cheminformatics (compound libraries, software tools and modeling), process development, pharmacology, drug metabolism and pharmacokinetics, molecular biology, biomarkers and clinical research. In July 2007, the US FDA approved Nicholas Piramal's Investigational New Drug (IND) application for its lead cancer compound P 276-00 to treat Multiple Myeloma. Nicholas Piramal is publicly committed to strong and effective intellectual property rights.
For more information on Nicholas Piramal, please go to: http://www.nicholaspiramal.com
About the IFPMA
The International Federation of Pharmaceutical Manufacturers & Associations is a non-profit, non-governmental organisation representing national industry associations and companies from both developed and developing countries. Member companies of the IFPMA are research-based pharmaceutical, biotech and vaccine companies.
http://www.ifpma.org
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |





